TAKEDA PHARMACEUTICAL COMPANY LIMITED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.28 EUR | +0.81% |
|
+2.69% | -6.74% |
| 06-25 | US CDC alerts healthcare providers of increase in dengue cases | RE |
| 06-25 | Takeda's Cancer Drug Gets European Commission Approval | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 40.6B | ||||||
| 819B | ||||||
| 351B | - | - | - | - | ||
| 329B | ||||||
| 298B | ||||||
| 242B |
